Immatics Biotechnologies GmbH - Company Profile
Powered by 
All the data and insights you need on Immatics Biotechnologies GmbH in one report.
$295
- Save hours of research time and resources with
our up-to-date Immatics Biotechnologies GmbH Strategy Report
- Understand Immatics Biotechnologies GmbH position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Immatics Biotechnologies GmbH (Immatics) is a clinical stage biopharmaceutical company that develops drugs for the treatment of cancer. It develops peptide based active immunotherapy drug candidates based on it novel technology, XPRESIDENT discovery platform. The company has active programs in several tumor types including gastric cancer, non-small-cell lung cancer, and prostate cancer. Its major drug candidates include IMA101, IMA201, IMA202, IMA203, and IMA301 which are focused on the development of three ACT approaches ACTolog, ACTengine, and ACTallo to treat cancer. The company has collaborations with Bristol Myers Squibb, Genmab, GSK, MD Anderson for the advancement of drug candidates. Immatics is headquartered in Tuebingen, Germany.
Headquarters
Germany
Address
Paul-Ehrlich-Strasse 15, Tuebingen, Baden-Wurttemberg, 72076
Website
www.immatics.com
Telephone
49 7071 53970
No of Employees
200
Industry
Pharmaceuticals and Healthcare
Immatics Biotechnologies GmbH premium industry data and analytics
Products and Services
| Products | Brands |
|---|---|
| Pipeline | ACTengine |
| IMA101 | ACTallo |
| IMA201 | ACTolog |
| XYZ | |
| XYZ | |
| XYZ |
Competitor Comparison
| Key Parameters | Immatics Biotechnologies GmbH | Immunocore Holdings Plc | Affimed GmbH | Generex Biotechnology Corp (Inactive) | Intezyne Inc |
|---|---|---|---|---|---|
| Headquarters | Germany | United Kingdom | Germany | United States of America | United States of America |
| City | Tuebingen | Abingdon | Mannheim | Miramar | Tampa |
| State/Province | Baden-Wurttemberg | England | Baden-Wurttemberg | Florida | Florida |
| No. of Employees | 200 | 408 | - | 8 | - |
| Entity Type | Private | Public | Private | Private | Private |
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Harpreet Singh, Ph.D. | Chief Executive Officer | Senior Management | 2019 | - |
| Cedrik Britten | Chief Medical Officer | Senior Management | 2020 | - |
| Rainer Kramer, Ph.D. | Chief Business Officer | Senior Management | 2012 | - |
| Carsten Reinhardt, M.D. Ph.D | Chief Development Officer | Senior Management | 2020 | - |
| Steffen Walter, Ph.D. | Chief Operating Officer | Senior Management | 2015 | - |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer